Literature DB >> 165489

Lack of detectable change in cyclic AMP during the cardiac inotropic response to isoproterenol immobilized on glass beads.

H C Venter, J Ross, N O Kaplan.   

Abstract

Changes in contractility and the levels of adenosine 3':5'-cyclic monophosphoric acid (cAMP) were assessed in isolated cat cardiac muscle in response to soluble isoproterenol and isoproterenol immobilized on glass beads. Drug-induced positive inotropic responses were compared to the maximum isometric force achieved with paired electrical stimulation, a potent physiological inotropic stimulus. Isoproterenol (1 muM) in solution increased the force of contraction 0.832 plus or minus 0.165 g at 60 sec in eight muscles tested, which at 60 and 120 sec averaged 65.5 plus or minus 6.5% and 82.9 plus or minus 8.8%, respectively, of the force with paired electrical stimulation. Isoproterenol immobilized on glass beads gave positive inotropic responses similar to those for the soluble form of the drug. Placement of only three isoproterenol-glass beads on the muscles increased the force of contraction 0.742 plus or minus 0.166 g at 60 sec (n equals 11), which at 60 and 120 sec averaged 45.1 plus or minus 7.0% and 58.6 plus or minus 6.4%, respectively, of the force with paired electrical stimulation. The magnitude of this response indicates that the increased force was developed by at least 60% of the cells in each muscle. Control levels of cAMP were 0.527 plus or minus 0.049 pmol/mg of tissue wet weight, n equals 11. cAMP levels 60 sec after 1 muM soluble isoproterenol was added were 1.212 plus or minus 0.085 pmol/mg; in contrast, the levels of cAMP in response to isoproterenol immobilized on glass beads at 60 sec were 0.490 plus or minus 0.060 pmol/mg, not significantly different from control levels. These data indicate that cAMP may not be involved in the propagation of the inotropic response that must have occurred in these cardiac muscles and raise questions as to the physiological significance of the large cAMP increases that occur in response to soluble drugs and hormones.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165489      PMCID: PMC432412          DOI: 10.1073/pnas.72.3.824

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  The structure and quantitation of catecholamines covalently bound to glass beads.

Authors:  J C Venter; L J Arnold; N O Kaplan
Journal:  Mol Pharmacol       Date:  1975-01       Impact factor: 4.436

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Cyclic changes in levels of cyclic AMP and cyclic GMP in frog myocardium during the cardiac cycle.

Authors:  A Wollenberger; E B Babskii; E G Krause; S Genz; D Blohm; E V Bogdanova
Journal:  Biochem Biophys Res Commun       Date:  1973-11-16       Impact factor: 3.575

Review 4.  Cyclic adenosine monophosphate and cardiac contractility.

Authors:  B E Sobel; S E Mayer
Journal:  Circ Res       Date:  1973-04       Impact factor: 17.367

5.  Interactions between changes in the intensity and duration of the active state in the characterization of inotropic stimuli on heart muscle.

Authors:  R A Buccino; E H Sonnenblick; J F Spann; W F Friedman; E Braunwald
Journal:  Circ Res       Date:  1967-12       Impact factor: 17.367

6.  Effect of epinephrine on phosphorylase b kinase in perfused rat hearts.

Authors:  G I Drummond; L Duncan; E Hertzman
Journal:  J Biol Chem       Date:  1966-12-25       Impact factor: 5.157

7.  Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

Authors:  A L Steiner; D M Kipnis; R Utiger; C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

8.  Blockade of biochemical and physiological responses of cardiac muscle to norepinephrine by N-tert.-butylmethoxamine (butoxamine).

Authors:  W B Wastila; J Y Su; W F Friedman; S E Mayer
Journal:  J Pharmacol Exp Ther       Date:  1972-04       Impact factor: 4.030

9.  Oscillation of cyclic adenosine monophosphate concentration during the myocardial contraction cycle.

Authors:  G Brooker
Journal:  Science       Date:  1973-11-20       Impact factor: 47.728

10.  Biologically active catecholamines covalentyly bound to glass beads.

Authors:  J C Venter; J E Dixon; P R Maroko; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

View more
  6 in total

Review 1.  Calcium transport by cardiac sarcoplasmic reticulum and phosphorylation of phospholamban.

Authors:  M Tada; M Yamada; M Kadoma; M Inui; F Ohmori
Journal:  Mol Cell Biochem       Date:  1982-07-23       Impact factor: 3.396

2.  Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.

Authors:  K Wildenthal; D O Allen; J Karlsson; J R Wakeland; C M Clark
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

3.  Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.

Authors:  A Hedberg; E Carlsson; E Fellenius; B Lundgren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

4.  The role of cyclic AMP in the positive inotropic effect mediated by beta 1- and beta 2-adrenoceptors in isolated human right atrium.

Authors:  K Ikezono; M C Michel; H R Zerkowski; J J Beckeringh; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

5.  Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.

Authors:  Jonas Jurevicius; V Arvydas Skeberdis; Rodolphe Fischmeister
Journal:  J Physiol       Date:  2003-06-18       Impact factor: 5.182

6.  Biological activity of catecholamines covalently linked to synthetic polymers: proof of immobilized drug theory.

Authors:  M S Verlander; J C Venter; M Goodman; N O Kaplan; B Saks
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.